$26 Billion United States Pharmaceutical Distributor Cardinal Health to Buy Integrated Oncology Network for $1.1 Billion in Cash, Integrated Oncology Network Supports Medical Oncology, Radiation Oncology, Urology, Diagnostic Testing & Ancillary Services
27th September 2024 | Hong Kong
United States pharmaceutical distributor Cardinal Health ($26 billion market value) has announced to buy Integrated Oncology Network for $1.115 billion in cash. Integrated Oncology Network supports Medical Oncology, Radiation Oncology, Urology, Diagnostic Testing & Ancillary Services. Cardinal Health (20/9/24): “Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Integrated Oncology Network (ION), a physician-led independent community oncology network, for $1.115B in cash. ION includes more than 50 practice sites in 10 states representing more than 100 providers with extensive reach into the local communities they serve. ION supports a complete continuum of care across its member sites including medical oncology, radiation oncology, urology, diagnostic testing and other ancillary services. The transaction builds on Cardinal Health’s commitment to helping community healthcare providers maintain their independence. As part of the transaction ION practices will become members of Navista, Cardinal Health’s oncology practice alliance, and ION practice management and practice growth services will become part of Navista’s advanced services and technology offering. ION practices will also have access to Navista’s advanced analytics capabilities that leverage artificial intelligence as well as deep expertise from Specialty Networks’ PPS Analytics and SoNaR technology solutions to generate actionable clinical and business insights.”
“ $26 Billion United States Pharmaceutical Distributor Cardinal Health to Buy Integrated Oncology Network for $1.1 Billion in Cash, Integrated Oncology Network Supports Medical Oncology, Radiation Oncology, Urology, Diagnostic Testing & Ancillary Services “
About Cardinal Health – Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With more than 50 years in business, operations in more than 30 countries and approximately 48,000 employees globally, Cardinal Health is essential to care.
About Integrated Oncology Network – Integrated Oncology Network partners directly with physicians, hospitals and other healthcare providers to offer the latest services and technologies to their patients. Founded in 2008, ION has grown to more than 50 centers across the country, providing a complete and integrated continuum of care including diagnostic testing, radiation oncology, medical oncology, urology and other ancillary services.
$26 Billion United States Pharmaceutical Distributor Cardinal Health to Buy Integrated Oncology Network for $1.1 Billion in Cash, Integrated Oncology Network Supports Medical Oncology, Radiation Oncology, Urology, Diagnostic Testing & Ancillary Services
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2024 Investment Day
- March 2024 - Hong Kong
- March 2024 - Singapore
- July 2024 - Hong Kong
- July 2024 - Singapore
- Sept 2024 - Hong Kong
- Sept 2024 - Singapore
- Oct 2024 - Hong Kong
- Nov 2024 - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
